SFDA Becomes First Global Regulator to Approve Frehemgo for Hemophilia A Bleeding Prevention
Riyadh: The Saudi Food and Drug Authority (SFDA) has become the first regulatory body globally to approve the registration of Frehemgo (denecimig) for the routine prophylaxis of bleeding episodes in patients with hemophilia A, with or without factor V…